These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26372401)

  • 1. EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.
    Olatunji BO; Rosenfield D; Monzani B; Krebs G; Heyman I; Turner C; Isomura K; Mataix-Cols D
    Depress Anxiety; 2015 Dec; 32(12):935-43. PubMed ID: 26372401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?
    Park JM; Small BJ; Geller DA; Murphy TK; Lewin AB; Storch EA
    J Child Fam Stud; 2014 Jul; 23(5):863-871. PubMed ID: 24999301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome.
    Wilhelm S; Berman N; Small BJ; Porth R; Storch EA; Geller D
    J Affect Disord; 2018 Dec; 241():454-460. PubMed ID: 30149332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Controlled Trial of OC-Go for Childhood Obsessive-Compulsive Disorder: Augmenting Homework Compliance in Exposure With Response Prevention Treatment.
    Tuerk PW; McGuire JF; Piacentini J
    Behav Ther; 2024 Mar; 55(2):306-319. PubMed ID: 38418042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
    Roque AD; Rosenfield D; Smits JAJ; Simon N; Otto MW; Marques L; Pollack MH; Hofmann SG; Meuret AE
    J Anxiety Disord; 2018 Jan; 53():85-90. PubMed ID: 29227845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.
    de Leeuw AS; van Megen HJ; Kahn RS; Westenberg HG
    Eur Psychiatry; 2017 Feb; 40():38-44. PubMed ID: 27837671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
    Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
    Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining cognitive-behavior therapy response and remission in pediatric OCD: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.
    Skarphedinsson G; De Nadai AS; Storch EA; Lewin AB; Ivarsson T
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):47-55. PubMed ID: 27209422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining Treatment Outcomes in Pediatric Obsessive-Compulsive Disorder Using a Self-Report Scale.
    McGuire JF; Geller DA; Murphy TK; Small BJ; Unger A; Wilhelm S; Storch EA
    Behav Ther; 2019 Mar; 50(2):314-324. PubMed ID: 30824248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial.
    Turner CM; Mataix-Cols D; Lovell K; Krebs G; Lang K; Byford S; Heyman I
    J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1298-1307.e2. PubMed ID: 25457928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Kvale G; Hansen B; Hagen K; Abramowitz JS; Børtveit T; Craske MG; Franklin ME; Haseth S; Himle JA; Hystad S; Kristensen UB; Launes G; Lund A; Solem S; Öst LG
    JAMA Netw Open; 2020 Aug; 3(8):e2013249. PubMed ID: 32789516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
    Højgaard DRMA; Hybel KA; Ivarsson T; Skarphedinsson G; Becker Nissen J; Weidle B; Melin K; Torp NC; Valderhaug R; Dahl K; Mortensen EL; Compton S; Jensen S; Lenhard F; Thomsen PH
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):940-947.e1. PubMed ID: 29096776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure and response prevention with or without parent management training for children with obsessive-compulsive disorder complicated by disruptive behavior: a multiple-baseline across-responses design study.
    Sukhodolsky DG; Gorman BS; Scahill L; Findley D; McGuire J
    J Anxiety Disord; 2013 Apr; 27(3):298-305. PubMed ID: 23602943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
    Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
    Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
    Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
    Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.